According to iHealthcareAnalyst, Inc ., the worldwide market for breast cancer therapeutics estimated to become $55.4 billion by 2031, expanding at a CAGR of 7.8% over the forecast period, driven by high unmet needs, improved cancer detection technologies, early diagnosis methods, increasing prevalence and incidence of breast cancer globally.

https://www.ihealthcareanalyst.com/higher-inc...cs-market/